Home  > 
  Takeda and BE enter tie-up to develop low-cost vaccines,   June 27, 2017
  Eli Lilly opens expanded biotechnology center in San Diego,   June 23, 2017
  Thermo Fisher Scientific launches workshop on genome editing technologies to guide researchers on CRISPR & TALEN,   June 19, 2017
  Twist Bioscience, BioBricks Foundation partner to provide 10,000 public-benefit genes to synthetic biology community,   June 16, 2017
  BioLife inks supply agreement with Adaptimmune for CryoStor use in SPEAR T-Cell platform,   June 15, 2017
  Indian Immunologicals set to expand its protozoan vaccine portfolio,   June 13, 2017
  AbCellera, Sanofi enter influenza vaccine research collaboration,   June 08, 2017
  Bharat Biotech’s Chikungunya vaccine enters phase 1 clinical trials,   June 05, 2017
  Pfizer' Trumenba receives EU approval for prevention of invasive meningococcal disease,   May 31, 2017
  IDT, Illumina partner to provide library preparation multiplexing and target enrichment solution for NGS market,   May 30, 2017
  Inovio Pharmaceuticals' HIV vaccine 'Pennvax-GP' shows nearly 100 per cent immune response rates in clinical study,   May 26, 2017
  Study shows helix transendocardial delivery system enables greater myocardial retention of stem cell therapy,   May 26, 2017
  Industry-Academia Collaborative Mission gets Centre's nod for accelerating discovery research to early development for biopharmaceuticals,   May 24, 2017
  EMA committee recommends approval of Sanofi's insulin lispro biosimilar,   May 22, 2017
  flanders.bio, JBA collaborate to get direct access to Japanese medicines market,   May 19, 2017
  Boehringer Ingelheim inaugurates biopharmaceutical facility in China,   May 18, 2017
  BrainStorm begins technology transfer to City of Hope for US production of NurOwn for phase 3 ALS study,   May 17, 2017
  Pfizer’s PCV 13 vaccine selected for inclusion in expansion of India’s immunization programme,   May 15, 2017
  India makes strategic shift from manufacture of chemicals to biological drugs: Peter Salazar,   May 13, 2017
  Takeda cancels launch of Vaxem Hib in Japan due to GSK decision to discontinue global production,   May 10, 2017

Copyright © 2016 Saffron Media Pvt. Ltd |